Compare JRSH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | VNRX |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.1M | 38.2M |
| IPO Year | 2018 | N/A |
| Metric | JRSH | VNRX |
|---|---|---|
| Price | $3.02 | $0.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $4.00 | $3.17 |
| AVG Volume (30 Days) | 88.4K | ★ 2.8M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | ★ 6.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $146,234,005.00 | $1,472,007.00 |
| Revenue This Year | $11.71 | $55.33 |
| Revenue Next Year | $7.69 | $493.79 |
| P/E Ratio | $61.26 | ★ N/A |
| Revenue Growth | 12.25 | ★ 14.48 |
| 52 Week Low | $2.81 | $0.27 |
| 52 Week High | $4.17 | $0.94 |
| Indicator | JRSH | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 28.10 |
| Support Level | $3.02 | $0.28 |
| Resistance Level | $3.15 | $0.31 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 20.45 | 3.77 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.